For example, ANLN and PRC1 were mutated in cells derived from a malignant melanoma [81], and RANBP2, TTK, PP2R1A, and CEP192 were mutated in cells from pancreatic cancers [82]. This evidence concerns the gene CEP192 and pancreatic neoplasm.